Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03288948
Other study ID # 062010-105
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 31, 2017
Est. completion date June 30, 2025

Study information

Verified date June 2023
Source Retina Foundation of the Southwest
Contact Reed Jost, MS
Phone 2143633911
Email reedjost@retinafoundation.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To evaluate the effectiveness of enhanced binocular amblyopia treatments in achieving a more complete and stable recovery.


Description:

To date, all studies of contrast-rebalanced binocular amblyopia treatment games used the same 10% per day contrast-increment that was designed for short-term intervention studies lasting 1-4 weeks; i.e., after 18 days of successful game play, both eyes viewed 100% contrast (no contrast-rebalancing).This study will investigate two alternative protocols designed to extend the game treatment period beyond 4 weeks to allow for more complete recovery of visual acuity. The new protocols will be compared with the original 10% contrast-increment game protocol in an 8-week 3-arm RCT to determine whether one or both of the new protocols is more effective than the current 10% increment. Based on pilot data, we expect about 40% of amblyopic children to achieve normal visual acuity in 8 weeks. In an effort to also promote recovery of binocular vision, children who attain ≤0.4 logMAR at 8 weeks will be enrolled in stereoacuity training at the 8-week visit for the next 4 weeks. Children with residual amblyopia (BCVA >0.4 logMAR) at the 8-week visit will be provided with dichoptic movies for additional amblyopia treatment for another 4 weeks.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date June 30, 2025
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender All
Age group 4 Years to 10 Years
Eligibility Inclusion Criteria: - age 4-10 y - male and female - strabismic, anisometropic, or combined mechanism amblyopia - amblyopic eye best-corrected visual acuity 0.3-0.8 logMAR - fellow eye best-corrected visual acuity =0.1 logMAR - interocular visual acuity difference =0.3 logMAR - wearing glasses (if needed) for 8 weeks or no change visual acuity with glasses at 2 visits - 4 weeks apart. - child's ophthalmologist and family must be willing to forgo patching treatment during the 12-week study period - parent's informed consent - child must demonstrate understanding and ability to play binocular games Exclusion Criteria: - prematurity =8 weeks - coexisting ocular or systemic disease - developmental delay - strabismus >5pd - any binocular amblyopia treatment in the past 3 months

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Binocular games for treatment of amblyopia
playing binocular games on a tablet platform 1 hour per day 5 days per week with reduced contrast for the fellow eye and high contrast for the amblyopic eye

Locations

Country Name City State
United States Retina Foundation of the Southwest Dallas Texas

Sponsors (1)

Lead Sponsor Collaborator
Retina Foundation of the Southwest

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Change in accommodation Accuracy of accommodation to a near target (Grand Seiko) baseline vs 8 week
Other Change in motion perception Motion-defined form baseline vs 8 weeks
Other Change in fixation stability Bivariate contour ellipse area baseline vs 8 weeks
Other Reading speed Reading speed in wpm baseline vs 4 and 8 weeks
Other Fine motor skills M-ABC baseline vs 4 and 8 weeks
Other Self-perception self-perception questionnaire baseline vs 8 weeks
Primary Change in visual acuity of the amblyopic eye ATS-HOTV for age 4-6.9 years or E-ETDRS for age 7-10.9 years baseline vs 8 weeks
Secondary Change in visual acuity of the amblyopic eye ATS-HOTV for age 4-6.9 years or E-ETDRS for age 7-10.9 years baseline vs 2, 4, 6, and 12 weeks
Secondary Change in stereoacuity Randot Preschool Stereoacuity Test baseline vs 2, 4, 6, 8, 12 weeks
Secondary Change in suppression Dichoptic Letter Chart baseline vs 2, 4, 6, 8, 12 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04238065 - A Clinical Trial of Caterna Virtual Reality Facilitating Treatment in Children With Amblyopia N/A
Completed NCT04432181 - Comparison of Deviation Types Among Astigmatic Children With Or Without Amblyopia
Terminated NCT02767856 - Regimens of Intermittent Occlusion Therapy for Amblyopia in Children N/A
Completed NCT02458846 - Efficacy of Visual Screening in Ontario N/A
Completed NCT01190813 - Levodopa for the Treatment of Residual Amblyopia Phase 3
Completed NCT01109459 - Multimodal Physician Intervention to Detect Amblyopia N/A
Completed NCT04313257 - Monocular Action Video Game Treatment of Amblyopia N/A
Completed NCT04315649 - Effect of 3D Movie Viewing on Stereopsis in Strabismus and / or Anisometropic Amblyops N/A
Completed NCT05223153 - OCT-A and Amblyopia
Recruiting NCT05522972 - Establishing New Treatment Approaches for Amblyopia: Perceptual Learning and Video Games N/A
Completed NCT01430247 - Vision Screening for the Detection of Amblyopia N/A
Completed NCT02200211 - Study of Binocular Computer Activities for Treatment of Amblyopia N/A
Recruiting NCT06429280 - Clinical Data Registry of Amblyopia Patients on Luminopia Treatment
Withdrawn NCT04959422 - Assuring Ophthalmologic Follow up N/A
Active, not recruiting NCT05612568 - 5 Years of Eye Screening for ARF in Children Aged <3 Years in Flanders
Recruiting NCT03655912 - Binocular Visual Therapy and Video Games for Amblyopia Treatment. N/A
Recruiting NCT06150391 - Evaluation of Amblyopia Protocols Using a Dichoptic Gabor Videogame Program N/A
Completed NCT03754153 - Binocularly Balanced Viewing Study N/A
Withdrawn NCT02594358 - Caffeine in Amblyopia Study Phase 1/Phase 2
Terminated NCT02246556 - Dichoptic Virtual Reality Therapy for Amblyopia in Adults Phase 1